Research and trials

Better evaluate adherence rates in clinical trials

Our flexible, asynchronous, video technology and person-to-person engagement scales the gold standard for medication adherence: Directly Observed Therapy.

Complete trials on schedule

We help you get started quickly and identify non-compliance early — helping you reduce patient dropout to get drugs to market faster.

Confirm dose-by-dose adherence

We facilitate the direct observation of each dose using patient-friendly and flexible video tech — allowing for more accurate drug efficacy measurements and improved patient engagement.

Increase diversity of participants

Our unique expertise helping historically underrepresented patient populations secure high-rates of adherence allows you to achieve diversity plan targets.
See our health equity statement.

An adherence platform that's easy to use, implement, and scale.

by [Scene]

Our easy-to-use mobile app. Patients log into Spotlight daily to submit daily video check-ins, anytime and anywhere. We make it fun for patients to stay on top of their medications and empower them to improve their health.

  • Easy-to-use, fun, and free to patients
  • Helps patients learn about their medications
  • Provides patients with a simple way to report and get help with medication problems, like side effects
  • Allows patients to easily track their progress
  • Offers configurable medication reminders
by [Scene]

The care team portal is designed to guide care teams through medication observation and engagement.

  • Dose-by-dose medication assessment
  • Robust adherence analytics
  • Livestream video appointments
  • Clinical escalation to relevant stakeholders
  • Missed submission alerts
  • Observation of SDOH & behavioral challenges
by [Scene]

Our escalation and engagement engine that helps institute a fast reaction to anything that looks worrisome.

  • Customizable rules engine
  • Observation of adherence challenges
  • Smart task list

We’re clinically validated

19 peer-reviewed journal articles from 12 clinical research studies and program evaluations report high levels of adherence to treatment with our adherence platform.

Johns Hopkins, State of Maryland, NIH
Florida State University, University of Florida
Hepatitis C
adherence among drug-using population
University of Colorado Anschutz Medical Campus, Gilead-supported
Journal of Asthma
TYPE 2 diabetes
Medicaid Health Plan
Published results pending

Trusted by leading institutions

[Scene's] customer service reps are much more friendly and knowledgeable about the system vs. another app that some studies use.”

Clinical Trial Manager, CRO

Peer reviewed study

Participants were twice as likely to complete their doses compared to those using wirelessly observed therapy
Median medication adherence among a drug-using cohort
In a drug trial with hepatitis C patients who inject drugs, researchers found that participants using Scene’s adherence platform had a higher adherence rate over an 84-dose regimen than those using a wireless pillbox technology.
Read study